Abstract:Heat shock protein (HSP)90 functions as a general oncogene by targeting several well-known oncoproteins for ubiquination and proteasomal degradation. However, the clinical significance of HSP90, as well as the mechanisms responsible for the tumor-promoting effects of HSP90 in hepatocellular carcinoma (HCC) remain unclear. In this study, HSP90 and hypoxia-inducible factor (HIF)-1 alpha expression in 60 samples of HCC tissues and matched normal tumor-adjacent tissue were assessed using immunohistochemistry (IHC) or western blot analysis. Flow cytometry, BrdU cell proliferation assay, caspase-3/7 activity assay and MTT assay were used to detect the apoptosis and proliferation of the HCC cells. The regulatory effect of HSP90 on HIF-1 alpha in the HCC cells was confirmed by immunofluorescence staining, western blot analysis and RT-qPCR. The interaction between HIF-1 alpha and HSP90 was analyzed by co-immunoprecipitation. A subcutaneous tumor xenograft model in nude mice was established and TUNEL assay was performed to evaluate cancer cell apoptosis and growth in vivo. We found that HSP90 expression was higher in the HCC tissues than in the normal tissues and that a high HSP90 expression correlated with poor clinicopathological characteristics, including venous infiltration, an advanced TNM stage and high pathological grading. Furthermore, we confirmed that patients with a negative expression of HSP90 had an improved 3-year survival, and that HSP90 was an independent factor for predicting the prognosis of patients with HCC. We demonstrated that HSP90 promoted HCC by inhibiting apoptosis and promoting cancer cell growth. Pearson's correlation coefficient analysis indicated that HSP90 expression positively correlated with HIF-1 alpha protein expression in the HCC tissues. Furthermore, we found that HSP90 regulated HIF-1 alpha protein abundance by inhibiting the ubiquitination and proteasomal degradation of HIF-1 alpha in HCC cells. Additionally, the upregulation of HIF-1 alpha expression partially abrogated HSP90 siRNA-induced HCC cell growth arrest and apoptosis in vitro and in vivo. These results indicate that HSP90 may be used as a prognostic marker and that HIF-1 alpha may be one of the potential therapeutic targets of HSP90 in HCC.

HSP27 expression levels are associated with the sensitivity of hepatocellular carcinoma

HSP27 Expression Levels Are Associated with the Sensitivity of Hepatocellular Carcinoma Cells to 17-Allylamino-17-demethoxygeldanamycin.

A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma

Expression and Biological Mechanism Exploration of Hsp27 in Different Metastatic Hcc Cell Lines

The Apoptotic Effect and Associated Signalling of Hsp90 Inhibitor 17-Dmag in Hepatocellular Carcinoma Cells

Inhibitory effect of 17AAG on proliferation and invasion of hepatocellular carcinoma cells

Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential

Inhibition of Heat-Shock Protein 90 Sensitizes Liver Cancer Stem-Like Cells to Magnetic Hyperthermia and Enhances Anti-Tumor Effect on Hepatocellular Carcinoma-Burdened Nude Mice

Targeting Heat Shock Factor-1 by Shrna Interference:A Potential Tool to Enhances Therapeutic Efficiency of 17-Aag on Colon Cancer in Vitro

HSP90 Interacts with HMGCR and Promotes the Progression of Hepatocellular Carcinoma.

The HSP90 inhibitor 17-AAG exhibits potent antitumor activity for pheochromocytoma in a xenograft model

HSP90 Inhibitor, 17-AAG, Inhibits Invasion of ATC by Down-Regulating HIF-1α

Hsp90 Inhibits Apoptosis And Promotes Growth By Regulating Hif-1 Alpha Abundance In Hepatocellular Carcinoma

Influence of 17AAG on proliferation and invasion of gastric cancer cell and its mechanism

Effect of HSP90 inhibitor on apoptosis in esophageal squamous carcinoma cell TE-1 and its mechanism

Effect of HSP90 Inhibitor in Pheochromocytoma PC12 Cells: an Experimental Investigation

Expression significance of heat shock protein 27, 70, 90α in hepatocellular carcinoma

Study on HSP90 Inhibitor of Potentiating Heat-Induced Cell Killing Osteosarcoma Cells

Targeting Grp75 Improves Hsp90 Inhibitor Efficacy By Enhancing P53-Mediated Apoptosis In Hepatocellular Carcinoma

17-allylamino-17-demethoxygeldanamycin impeded chemotherapy through antioxidant activation via reducing reactive oxygen species-induced cell death.

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors